Cellular effects of pyocyanin, a secreted virulence factor of Pseudomonas aeruginosa

Toxins

Volumn 8, Issue 8, 2016, Pages

  Hall, Susan ^a   McDermott, Catherine ^b   Anoopkumar Dukie, Shailendra ^a   McFarland, Amelia J ^a   Forbes, Amanda ^b   Perkins, Anthony V ^a   Davey, Andrew K ^a   Chess Williams, Russ ^b   Kiefel, Milton J ^a   Arora, Devinder ^a   Grant, Gary D ^a  

^a GRIFFITH UNIVERSITY   (Australia)

^b BOND UNIVERSITY   (Australia)

Author keywords

Inflammation; Oxidative stress; Pseudomonas aeruginosa; Pyocyanin; Virulence factor

Indexed keywords

CATALASE; EPIDERMAL GROWTH FACTOR RECEPTOR; GLUTATHIONE PEROXIDASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 2; MACROPHAGE INFLAMMATORY PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PYOCYANINE; SUPEROXIDE DISMUTASE; VIRULENCE FACTOR; AUTACOID; REACTIVE OXYGEN METABOLITE;

CELL INTERACTION; CELL PROLIFERATION; CHEMICAL STRUCTURE; CYSTIC FIBROSIS; IMMUNOMODULATION; INFLAMMATION; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; PSEUDOMONAS AERUGINOSA; REVIEW; TISSUE INJURY; UPREGULATION; URINARY TRACT INFECTION; ANIMAL; HUMAN; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; PATHOGENICITY; PSEUDOMONAS INFECTION;

ANIMALS; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; OXIDATIVE STRESS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; PYOCYANINE; REACTIVE OXYGEN SPECIES; VIRULENCE FACTORS;

EID: 84982275962     PISSN: None     EISSN: 20726651     Source Type: Journal    
DOI: 10.3390/toxins8080236     Document Type: Review

References (98)

1. Lyczak, J.B.; Cannon, C.L.; Pier, G.B. Establishment of pseudomonas aeruginosa infection: Lessons from a versatile opportunist. Microbes Infect. 2000, 2, 1051–1060.
2. Mittal, R.; Aggarwal, S.; Sharma, S.; Chhibber, S.; Harjai, K. Urinary tract infections caused by pseudomonas aeruginosa: A minireview. J. Infect. Pub. Health 2009, 2, 101–111.
3. Polovina, M.; Potpara, T.; Milosevic, I.; Stepanovic, J.; Jovanovic, M.; Pavlovic, M. Mitral valve endocarditis caused by pseudomonas aeruginosa: A case report. J. Infect. Dev. Ctries. 2014, 8, 676–679.
4. Seyman, D.; Inan, D.; Sepin Ozen, N.; Ogunc, D. An outbreak of pseudomonas aeruginosa infective endocarditis subsequent to coronary angiography. Rev. Chil. Infectol. 2014, 31, 268–273.
5. Setoguchi, M.; Iwasawa, E.; Hashimoto, Y.; Isobe, M. A patient with infective endocarditis caused by community-acquired pseudomonas aeruginosa infection. Intern. Med. 2013, 52, 1259–1262.
6. Archer, G.; Fekety, F.R.; Supena, R. Pseudomonas aeruginosa endocarditis in drug addicts. Am. Heart J. 1974, 88, 570–578.
7. Chuang, Y.; Chang, W.; Lu, C.; Wu, H.; Chang, H. Pseudomonas aeruginosa central nervous system infections: Analysis of clinical features of 16 adult patients. Zhonghua Yi Xue Za Zhi 1999, 62, 300–307.
8. Turner, J.M.; Messenger, A.J. Occurrence, biochemistry and physiology of phenazine pigment production. Adv. Microb. Physiol. 1986, 27, 211–275.
9. Oliver, A.; Cantón, R.; Campo, P.; Baquero, F.; Blázquez, J. High frequency of hypermutable pseudomonas aeruginosa in cystic fibrosis lung infection. Science 2000, 288, 1251–1253.
10. 1 -dichlorodihydrofluorescein by pyocyanin and other redox-active compounds independent of reactive oxygen species production. Free Radic. Biol. Med. 2004, 36, 90–100.
11. O’Malley, Y.Q.; Reszka, K.J.; Spitz, D.R.; Denning, G.M.; Britigan, B.E. Pseudomonas aeruginosa pyocyanin directly oxidizes glutathione and decreases its levels in airway epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 2004, 287, L94–L103.
12. Reszka, K.J.; O’Malley, Y.; McCormick, M.L.; Denning, G.M.; Britigan, B.E. Oxidation of pyocyanin, a cytotoxic product from pseudomonas aeruginosa, by microperoxidase 11 and hydrogen peroxide. Free Radic. Biol. Med. 2004, 36, 1448–1459.
13. Wilson, R.; Dowling, R.B. Pseudomonas aeruginosa and other related species. Thorax 1998, 53, 213–219.
14. Lau, G.W.; Hassett, D.J.; Ran, H.; Kong, F. The role of pyocyanin in pseudomonas aeruginosa infection. Trends Mol. Med. 2004, 10, 599–606.
15. Fothergill, J.L.; Panagea, S.; Hart, C.A.; Walshaw, M.J.; Pitt, T.L.; Winstanley, C. Widespread pyocyanin over-production among isolates of a cystic fibrosis epidemic strain. BMC Microbiol. 2007, 7, 45.
16. Baron, S.S.; Rowe, J.J. Antibiotic action of pyocyanin. Antimicrob. Agents Chemother. 1981, 20, 814–820.
17. Gardner, P.R. Superoxide production by the mycobacterial and pseudomonad quinoid pigments phthiocol and pyocyanine in human lung cells. Arch. Biochem. Biophys. 1996, 333, 267–274.
18. Friedheim, E.A. Pyocyanine, an accessory respiratory enzyme. J. Exp. Med. 1931, 54, 207–221.
19. Van Delden, C.; Iglewski, B.H. Cell-to-cell signaling and pseudomonas aeruginosa infections. Emerg. Infect. Dis. 1998, 4, 551–560.
20. Reimer, A.; Edvaller, B.; Johansson, B. Concentrations of the pseudomonas aeruginosa toxin pyocyanin in human ear secretions. Acta Otolaryngol. Suppl. 2000, 543, 86–88.
21. Wilson, R.; Sykes, D.A.; Watson, D.; Rutman, A.; Taylor, G.W.; Cole, P.J. Measurement of pseudomonas aeruginosa phenazine pigments in sputum and assessment of their contribution to sputum sol toxicity for respiratory epithelium. Infect. Immun 1988, 56, 2515–2517.
22. Cruickshank, C.N.; Lowbury, E.J. The effect of pyocyanin on human skin cells and leucocytes. Br. J. Exp. Pathol. 1953, 34, 583–587.
23. Lau, G.W.; Ran, H.; Kong, F.; Hassett, D.J.; Mavrodi, D. Pseudomonas aeruginosa pyocyanin is critical for lung infection in mice. Infect. Immun 2004, 72, 4275–4278.
24. Smith, K.M.; Bu, Y.; Suga, H. Induction and inhibition of pseudomonas aeruginosa quorum sensing by synthetic autoinducer analogs. Chem. Biol. 2003, 10, 81–89.
25. Britigan, B.E.; Roeder, T.L.; Rasmussen, G.T.; Shasby, D.M.; McCormick, M.L.; Cox, C.D. Interaction of the pseudomonas aeruginosa secretory products pyocyanin and pyochelin generates hydroxyl radical and causes synergistic damage to endothelial cells. Implications for pseudomonas-associated tissue injury. J. Clin. Investig. 1992, 90, 2187–2196.
26. Denning, G.M.; Wollenweber, L.A.; Railsback, M.A.; Cox, C.D.; Stoll, L.L.; Britigan, B.E. Pseudomonas pyocyanin increases interleukin-8 expression by human airway epithelial cells. Infect. Immun 1998, 66, 5777–5784.
27. McDermott, C.; Chess-Williams, R.; Mills, K.A.; Kang, S.H.; Farr, S.E.; Grant, G.D.; Perkins, A.V.; Davey, A.K.; Anoopkumar-Dukie, S. Alterations in acetylcholine, pge2 and il6 release from urothelial cells following treatment with pyocyanin and lipopolysaccharide. Toxicol. Vitro Intern. J. Publ. Assoc. BIBRA 2013, 27, 1693–1698.
28. McDermott, C.; Chess-Williams, R.; Grant, G.D.; Perkins, A.V.; McFarland, A.J.; Davey, A.K.; Anoopkumar-Dukie, S. Effects of pseudomonas aeruginosa virulence factor pyocyanin on human urothelial cell function and viability. J. Urol. 2012, 187, 1087–1093.
29. Hempenstall, A.; Grant, G.D.; Anoopkumar-Dukie, S.; Johnson, P.J. Pyocyanin inhibits both nitric oxide-dependent and independent relaxation in porcine coronary arteries. Clin. Exp. Pharmacol. Physiol. 2014.
30. McFarland, A.J.; Anoopkumar-Dukie, S.; Perkins, A.V.; Davey, A.K.; Grant, G.D. Inhibition of autophagy by 3-methyladenine protects 1321n1 astrocytoma cells against pyocyanin- and 1-hydroxyphenazine-induced toxicity. Arch. Toxicol. 2012, 86, 275–284.
31. McFarland, A.J.; Grant, G.D.; Perkins, A.V.; Flegg, C.; Davey, A.K.; Allsopp, T.J.; Renshaw, G.; Kavanagh, J.; McDermott, C.M.; Anoopkumar-Dukie, S. Paradoxical role of 3-methyladenine in pyocyanin-induced toxicity in 1321n1 astrocytoma and sh-sy5y neuroblastoma cells. Intern. J. Toxicol. 2013, 32, 209–218.
32. Muller, M. Pyocyanin induces oxidative stress in human endothelial cells and modulates the glutathione redox cycle. Free Radic. Biol. Med. 2002, 33, 1527–1533.
33. Cheluvappa, R.; Jamieson, H.A.; Hilmer, S.N.; Muller, M.; Le Couteur, D.G. The effect of pseudomonas aeruginosa virulence factor, pyocyanin, on the liver sinusoidal endothelial cell. J. Gastroenterol. Hepatol. 2007, 22, 1350–1351.
34. Muller, M. Premature cellular senescence induced by pyocyanin, a redox-active pseudomonas aeruginosa toxin. Free Radic. Biol. Med. 2006, 41, 1670–1677.
35. Davis, G.; Thornalley, P.J. Free radical production from the aerobic oxidation of reduced pyridine nucleotides catalysed by phenazine derivatives. Biochim. Biophys. Acta 1983, 724, 456–464.
36. Britigan, B.E.; Railsback, M.A.; Cox, C.D. The pseudomonas aeruginosa secretory product pyocyanin inactivates alpha1 protease inhibitor: Implications for the pathogenesis of cystic fibrosis lung disease. Infect. Immun 1999, 67, 1207–1212.
37. Ran, H.; Hassett, D.J.; Lau, G.W. Human targets of pseudomonas aeruginosa pyocyanin. Proc. Natl. Acad. Sci. USA. 2003, 100, 14315–14320.
38. O’Malley, Y.Q.; Abdalla, M.Y.; McCormick, M.L.; Reszka, K.J.; Denning, G.M.; Britigan, B.E. Subcellular localization of pseudomonas pyocyanin cytotoxicity in human lung epithelial cells. Am. J. Phys. Lung Cell. Mol. Phys. 2003, 284, L420–L430.
39. Rada, B.; Leto, T.L. Pyocyanin effects on respiratory epithelium: Relevance in pseudomonas aeruginosa airway infections. Trends Microbiol. 2013, 21, 73–81.
40. Das, T.; Manefield, M. Pyocyanin promotes extracellular DNA release in pseudomonas aeruginosa. PLoS ONE 2012, 7, e46718.
41. Suntres, Z.E.; Omri, A.; Shek, P.N. Pseudomonas aeruginosa-induced lung injury: Role of oxidative stress. Microbial Pathog. 2002, 32, 27–34.
42. Rada, B.; Gardina, P.; Myers, T.G.; Leto, T.L. Reactive oxygen species mediate inflammatory cytokine release and egfr-dependent mucin secretion in airway epithelial cells exposed to pseudomonas pyocyanin. Mucosal Immunol. 2011, 4, 158–171.
43. Bannister, J.V.; Bannister, W.H.; Rotilio, G. Aspects of the structure, function, and applications of superoxide dismutase. CRC Crit. Rev. Biochem. 1987, 22, 111–180.
44. Heffner, J.E.; Repine, J.E. Pulmonary strategies of antioxidant defense. Am. Rev. Respir. Dis. 1989, 140, 531–554.
45. Dickinson, D.A.; Forman, H.J. Cellular glutathione and thiols metabolism. Biochem. Pharmacol. 2002, 64, 1019–1026.
46. Powis, G.; Montfort, W.R. Properties and biological activities of thioredoxins. Ann. Rev. Biophys. Biomol. Struct. 2001, 30, 421–455.
47. Aquilano, K.; Baldelli, S.; Ciriolo, M.R. Glutathione: New roles in redox signaling for an old antioxidant. Front. Pharmacol. 2014, 5, 196.
48. Gloyne, L.S.; Grant, G.D.; Perkins, A.V.; Powell, K.L.; McDermott, C.M.; Johnson, P.V.; Anderson, G.J.; Kiefel, M.; Anoopkumar-Dukie, S. Pyocyanin-induced toxicity in a549 respiratory cells is causally linked to oxidative stress. Toxicol. Vitro Intern. J. Publ. Assoc. BIBRA 2011, 25, 1353–1358.
49. Forbes, A.; Davey, A.K.; Perkins, A.V.; Grant, G.D.; McFarland, A.J.; McDermott, C.M.; Anoopkumar-Dukie, S. Erk1/2 activation modulates pyocyanin-induced toxicity in a549 respiratory epithelial cells. Chem-Biol. Interact. 2014, 208, 58–63.
50. Lauredo, I.T.; Sabater, J.R.; Ahmed, A.; Botvinnikova, Y.; Abraham, W.M. Mechanism of pyocyanin- and 1-hydroxyphenazine-induced lung neutrophilia in sheep airways. J. Appl. Physiol. 1998, 85, 2298–2304.
51. Cheluvappa, R.; Cogger, V.C.; Kwun, S.Y.; O’Reilly, J.N.; Le Couteur, D.G.; Hilmer, S.N. Liver sinusoidal endothelial cells and acute non-oxidative hepatic injury induced by pseudomonas aeruginosa pyocyanin. Intern. J. Exp. Pathol. 2008, 89, 410–418.
52. Leidal, K.G.; Munson, K.L.; Denning, G.M. Small molecular weight secretory factors from pseudomonas aeruginosa have opposite effects on il-8 and rantes expression by human airway epithelial cells. Am. J. Respir. Cell Mol. Biol. 2001, 25, 186–195.
53. Nutman, J.; Berger, M.; Chase, P.A.; Dearborn, D.G.; Miller, K.M.; Waller, R.L.; Sorensen, R.U. Studies on the mechanism of t cell inhibition by the pseudomonas aeruginosa phenazine pigment pyocyanine. J. Immunol. 1987, 138, 3481–3487.
54. Ulmer, A.J.; Pryjma, J.; Tarnok, Z.; Ernst, M.; Flad, H.D. Inhibitory and stimulatory effects of pseudomonas aeruginosa pyocyanine on human t and b lymphocytes and human monocytes. Infect. Immun. 1990, 58, 808–815.
55. Prince, L.R.; Bianchi, S.M.; Vaughan, K.M.; Bewley, M.A.; Marriott, H.M.; Walmsley, S.R.; Taylor, G.W.; Buttle, D.J.; Sabroe, I.; Dockrell, D.H.; et al. Subversion of a lysosomal pathway regulating neutrophil apoptosis by a major bacterial toxin, pyocyanin. J. Immunol. 2008, 180, 3502–3511.
56. Gibson, J.; Sood, A.; Hogan, D.A. Pseudomonas aeruginosa-candida albicans interactions: Localization and fungal toxicity of a phenazine derivative. Appl. Environ. Microbiol. 2009, 75, 504–513.
57. Mavrodi, D.V.; Bonsall, R.F.; Delaney, S.M.; Soule, M.J.; Phillips, G.; Thomashow, L.S. Functional analysis of genes for biosynthesis of pyocyanin and phenazine-1-carboxamide from pseudomonas aeruginosa pao1. J. Bacteriol. 2001, 183, 6454–6465.
58. Chai, W.; Zhang, J.; Zhu, Z.; Liu, W.; Pan, D.; Li, Y.; Chen, B. Pyocyanin from pseudomonas induces il-8 production through the pkc and nf-κb pathways in u937 cells. Mol. Med. Rep. 2013, 8, 1404–1410.
59. Chai, W.; Zhang, J.; Duan, Y.; Pan, D.; Liu, W.; Li, Y.; Yan, X.; Chen, B. Pseudomonas pyocyanin stimulates il-8 expression through mapk and nf-κb pathways in differentiated u937 cells. BMC Microbiol. 2014, 14, 1.
60. Usher, L.R.; Lawson, R.A.; Geary, I.; Taylor, C.J.; Bingle, C.D.; Taylor, G.W.; Whyte, M.K. Induction of neutrophil apoptosis by the pseudomonas aeruginosa exotoxin pyocyanin: A potential mechanism of persistent infection. J. Immunol. 2002, 168, 1861–1868.
61. Allen, L.; Dockrell, D.H.; Pattery, T.; Lee, D.G.; Cornelis, P.; Hellewell, P.G.; Whyte, M.K. Pyocyanin production by pseudomonas aeruginosa induces neutrophil apoptosis and impairs neutrophil-mediated host defenses in vivo. J. Immunol. 2005, 174, 3643–3649.
62. Manago, A.; Becker, K.A.; Carpinteiro, A.; Wilker, B.; Soddemann, M.; Seitz, A.P.; Edwards, M.J.; Grassmé, H.; Szabo, I.; Gulbins, E. Pseudomonas aeruginosa pyocyanin induces neutrophil death via mitochondrial reactive oxygen species and mitochondrial acid sphingomyelinase. Antioxid. Redox signal. 2015, 22, 1097–1110.
63. Bruce, M.C.; Poncz, L.; Klinger, J.D.; Stern, R.C.; Tomashefski, J.F., Jr.; Dearborn, D.G. Biochemical and pathologic evidence for proteolytic destruction of lung connective tissue in cystic fibrosis. Am. Rev. Respir. Dis. 1985, 132, 529–535.
64. Lyczak, J.B.; Cannon, C.L.; Pier, G.B. Lung infections associated with cystic fibrosis. Clin. Microbiol. Rev. 2002, 15, 194–222.
65. Rosenfeld, M.; Gibson, R.L.; McNamara, S.; Emerson, J.; Burns, J.L.; Castile, R.; Hiatt, P.; McCoy, K.; Wilson, C.B.; Inglis, A.; et al. Early pulmonary infection, inflammation, and clinical outcomes in infants with cystic fibrosis. Pediatr. Pulmonol. 2001, 32, 356–366.
66. Hassan, H.M.; Fridovich, I. Mechanism of the antibiotic action pyocyanine. J. Bacteriol. 1980, 141, 156–163.
67. Gibson, R.L.; Burns, J.L.; Ramsey, B.W. Pathophysiology and management of pulmonary infections in cystic fibrosis. Am. J. Respir. Criti. Care Med. 2003, 168, 918–951.
68. Bianchi, S.M.; Prince, L.R.; McPhillips, K.; Allen, L.; Marriott, H.M.; Taylor, G.W.; Hellewell, P.G.; Sabroe, I.; Dockrell, D.H.; Henson, P.W.; et al. Impairment of apoptotic cell engulfment by pyocyanin, a toxic metabolite of pseudomonas aeruginosa. Am. J. Respir. Criti. Care Med. 2008, 177, 35–43.
69. Schall, T.J.; Bacon, K.; Toy, K.J.; Goeddel, D.V. Selective attraction of monocytes and t lymphocytes of the memory phenotype by cytokine rantes. Nature 1990, 347, 669–671.
70. Hunter, R.C.; Klepac-Ceraj, V.; Lorenzi, M.M.; Grotzinger, H.; Martin, T.R.; Newman, D.K. Phenazine content in the cystic fibrosis respiratory tract negatively correlates with lung function and microbial complexity. Am. J. Respir. Cell Mol. Biol. 2012, 47, 738–745.
71. Look, D.C.; Stoll, L.L.; Romig, S.A.; Humlicek, A.; Britigan, B.E.; Denning, G.M. Pyocyanin and its precursor phenazine-1-carboxylic acid increase il-8 and intercellular adhesion molecule-1 expression in human airway epithelial cells by oxidant-dependent mechanisms. J. Immunol. 2005, 175, 4017–4023.
72. Hao, Y.; Kuang, Z.; Walling, B.E.; Bhatia, S.; Sivaguru, M.; Chen, Y.; Gaskins, H.R.; Lau, G.W. Pseudomonas aeruginosa pyocyanin causes airway goblet cell hyperplasia and metaplasia and mucus hypersecretion by inactivating the transcriptional factor foxa2. Cell. Microbiol. 2012, 14, 401–415.
73. Munro, N.; Barker, A.; Rutman, A.; Taylor, G.; Watson, D.; McDonald-Gibson, W.; Towart, R.; Taylor, W.; Wilson, R.; Cole, P. Effect of pyocyanin and 1-hydroxyphenazine on in vivo tracheal mucus velocity. J. Appl. Physiol. 1989, 67, 316–323.
74. O’Malley, Y.Q.; Reszka, K.J.; Rasmussen, G.T.; Abdalla, M.Y.; Denning, G.M.; Britigan, B.E. The pseudomonas secretory product pyocyanin inhibits catalase activity in human lung epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 2003, 285, L1077–L1086.
75. Al-Ani, F.Y.; Al-Shibib, A.S.; Khammas, K.M.; Taher, R. Pyocyanin preparation from pseudomonas aeruginosa isolated from heterogeneous clinical materials. Folia Microbiol. 1986, 31, 215–219.
76. Muller, M.; Li, Z.; Maitz, P.K.M. Pseudomonas pyocyanin inhibits wound repair by inducing premature cellular senescence: Role for p38 mitogen-activated protein kinase. Burns J. Intern. Soc. Burn Inj. 2009, 35, 500–508.
77. Gryglewski, R.J.; Zembowicz, A.; Salvemini, D.; Taylor, G.W.; Vane, J.R. Modulation of the pharmacological actions of nitrovasodilators by methylene blue and pyocyanin. Br. J. Pharmacol. 1992, 106, 838–845.
78. Poore, S.; Berry, B.; Eidson, D.; McKie, K.T.; Harris, R.A. Evidence of vascular endothelial dysfunction in young patients with cystic fibrosis. Chest 2013, 143, 939–945.
79. Huang, Y.C.; Lin, T.Y.; Wang, C.H. Community-acquired pseudomonas aeruginosa sepsis in previously healthy infants and children: Analysis of forty-three episodes. Pediatr. Infect. Dis. J. 2002, 21, 1049–1052.
80. Boquist, L.; Bostrom, T. Alloxan effects on mitochondria in vitro, studied with regard to inhibition of mitochondrial aconitase. Diabete Metab. 1985, 11, 232–237.
81. Boquist, L.; Ericsson, I.; Lorentzon, R.; Nelson, L. Alterations in mitochondrial aconitase activity and respiration, and in concentration of citrate in some organs of mice with experimental or genetic diabetes. FEBS Lett. 1985, 183, 173–176.
82. Cuestas, R.; Dixit, P.K. Citrate metabolic enzymes in alloxan diabetes. Proc. Soc. Exp. Biol. Med. Soc. Exp. Biol. Med. 1973, 142, 889–895.
83. Cuestas, R.; Dixit, P.K. Oxidation, accumulation, and turnover of citrate in normal and diabetic rats. Proc. Soc. Exp. Biol. Med. Soc. Exp. Biol. Med. 1974, 147, 181–187.
84. Ceriello, A.; Motz, E. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler. Thromb. Vasc. Biol. 2004, 24, 816–823.
85. Hassett, D.J.; Charniga, L.; Bean, K.; Ohman, D.E.; Cohen, M.S. Response of pseudomonas aeruginosa to pyocyanin: Mechanisms of resistance, antioxidant defenses, and demonstration of a manganese-cofactored superoxide dismutase. Infect. Immun 1992, 60, 328–336.
86. Sun-Wada, G.H.; Toyomura, T.; Murata, Y.; Yamamoto, A.; Futai, M.; Wada, Y. The a3 isoform of v-atpase regulates insulin secretion from pancreatic beta-cells. J. Cell Sci. 2006, 119, 4531–4540.
87. Kong, F.; Young, L.; Chen, Y.; Ran, H.; Meyers, M.; Joseph, P.; Cho, Y.-H.; Hasset, D.J.; Lau, G.W. Pseudomonas aeruginosa pyocyanin inactivates lung epithelial vacuolar atpase-dependent cystic fibrosis transmembrane conductance regulator expression and localization. Cell. Microbiol. 2006, 8, 1121–1133.
88. Mahajan-Miklos, S.; Tan, M.-W.; Rahme, L.G.; Ausubel, F.M. Molecular mechanisms of bacterial virulence elucidated using a pseudomonas aeruginosa–caenorhabditis elegans pathogenesis model. Cell 1999, 96, 47–56.
89. Melo, J.A.; Ruvkun, G. Inactivation of conserved c. Elegans genes engages pathogen-and xenobiotic-associated defenses. Cell 2012, 149, 452–466.
90. Pellegrino, M.W.; Nargund, A.M.; Kirienko, N.V.; Gillis, R.; Fiorese, C.J.; Haynes, C.M. Mitochondrial upr-regulated innate immunity provides resistance to pathogen infection. Nature 2014, 516, 414–417.
91. Liu, Y.; Samuel, B.S.; Breen, P.C.; Ruvkun, G. Caenorhabditis elegans pathways that surveil and defend mitochondria. Nature 2014, 508, 406–410.
92. Miller, L.C.; O’Loughlin, C.T.; Zhang, Z.; Siryaporn, A.; Silpe, J.E.; Bassler, B.L.; Semmelhack, M.F. Development of potent inhibitors of pyocyanin production in pseudomonas aeruginosa. J. Med. Chem. 2015, 58, 1298–1306.
93. Morkunas, B.; Galloway, W.R.; Wright, M.; Ibbeson, B.M.; Hodgkinson, J.T.; O’Connell, K.M.; Bartolucci, N.; Della Valle, M.; Welch, M.; Spring, D.R. Inhibition of the production of the pseudomonas aeruginosa virulence factor pyocyanin in wild-type cells by quorum sensing autoinducer-mimics. Org. Biomol. Chem. 2012, 10, 8452–8464.
94. Ishida, T.; Ikeda, T.; Takiguchi, N.; Kuroda, A.; Ohtake, H.; Kato, J. Inhibition of quorum sensing in pseudomonas aeruginosa by n-acyl cyclopentylamides. Appl. Environ. Microbiol. 2007, 73, 3183–3188.
95. O’Loughlin, C.T.; Miller, L.C.; Siryaporn, A.; Drescher, K.; Semmelhack, M.F.; Bassler, B.L. A quorum-sensing inhibitor blocks pseudomonas aeruginosa virulence and biofilm formation. Proc. Natl. Acad. Sci. USA 2013, 110, 17981–17986.
96. Morkunas, B.; Gal, B.; Galloway, W.R.; Hodgkinson, J.T.; Ibbeson, B.M.; Tan, Y.S.; Welch, M.; Spring, D.R. Discovery of an inhibitor of the production of the pseudomonas aeruginosa virulence factor pyocyanin in wild-type cells. Beilsten J. Org. Chem. 2016, 12, 1428–1433.
97. Ugurlu, A.; Karahasan Yagci, A.; Ulusoy, S.; Aksu, B.; Bosgelmez-Tinaz, G. Phenolic compounds affect production of pyocyanin, swarming motility and biofilm formation of pseudomonas aeruginosa. Asian Pac. J. Trop. Biomed. 2016, 6, 698–701.
98. Ho Sui, S.J.; Lo, R.; Fernandes, A.R.; Caulfield, M.D.G.; Lerman, J.A.; Xie, L.; Bourne, P.E.; Baillie, D.L.; Brinkman, F.S.L. Raloxifene attenuates pseudomonas aeruginosa pyocyanin production and virulence. Intern. J. Antimicrob. Agents 2012, 40, 246–251.